Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytosine arabinoside as a single agent for the induction of remission in canine lymphoma.
Ruslander D, Moore AS, Gliatto JM, L'Heureux D, Cotter SM. Ruslander D, et al. J Vet Intern Med. 1994 Jul-Aug;8(4):299-301. doi: 10.1111/j.1939-1676.1994.tb03237.x. J Vet Intern Med. 1994. PMID: 7983628
Cytosine arabinoside (AraC) was administered as a continuous IV infusion to 15 dogs with malignant lymphoma at a dose of 300 mg/m2/d for 2 consecutive days. Dogs were re-examined 7 d after treatment for response to therapy and for hematologic toxicity. Regardless of …
Cytosine arabinoside (AraC) was administered as a continuous IV infusion to 15 dogs with malignant lymphoma at a dose of 300 mg/m2/d
2016 AAHA Oncology Guidelines for Dogs and Cats.
Biller B, Berg J, Garrett L, Ruslander D, Wearing R, Abbott B, Patel M, Smith D, Bryan C. Biller B, et al. Among authors: ruslander d. J Am Anim Hosp Assoc. 2016 Jul-Aug;52(4):181-204. doi: 10.5326/JAAHA-MS-6570. Epub 2016 Jun 3. J Am Anim Hosp Assoc. 2016. PMID: 27259020
Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
Bailey D, Erb H, Williams L, Ruslander D, Hauck M. Bailey D, et al. Among authors: ruslander d. J Vet Intern Med. 2003 Mar-Apr;17(2):199-205. doi: 10.1111/j.1939-1676.2003.tb02434.x. J Vet Intern Med. 2003. PMID: 12683621 Clinical Trial.
Light-chain myeloma in a dog.
Cowgill ES, Neel JA, Ruslander D. Cowgill ES, et al. Among authors: ruslander d. J Vet Intern Med. 2004 Jan-Feb;18(1):119-21. doi: 10.1892/0891-6640(2004)18<119:lmiad>2.0.co;2. J Vet Intern Med. 2004. PMID: 14765743 No abstract available.
Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
Kleiter M, Malarkey DE, Ruslander DE, Thrall DE. Kleiter M, et al. Among authors: ruslander de. Vet Radiol Ultrasound. 2004 May-Jun;45(3):255-60. doi: 10.1111/j.1740-8261.2004.04046.x. Vet Radiol Ultrasound. 2004. PMID: 15200266
Potential tumour doubling time: determination of Tpot for various canine and feline tumours.
Schwyn U, Crompton NE, Blattmann H, Hauser B, Klink B, Parvis A, Ruslander D, Kaser-Hotz B. Schwyn U, et al. Among authors: ruslander d. Vet Res Commun. 1998 Jun;22(4):233-47. doi: 10.1023/a:1006087114421. Vet Res Commun. 1998. PMID: 9686438
A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs.
Vail DM, von Euler H, Rusk AW, Barber L, Clifford C, Elmslie R, Fulton L, Hirschberger J, Klein M, London C, Martano M, McNiel EA, Morris JS, Northrup N, Phillips B, Polton G, Post G, Rosenberg M, Ruslander D, Sahora A, Siegel S, Thamm D, Westberg S, Winter J, Khanna C. Vail DM, et al. Among authors: ruslander d. J Vet Intern Med. 2012 May-Jun;26(3):598-607. doi: 10.1111/j.1939-1676.2012.00897.x. Epub 2012 Mar 6. J Vet Intern Med. 2012. PMID: 22390318 Free PMC article. Clinical Trial.
Detection and molecular characterization of a novel large Babesia species in a dog.
Birkenheuer AJ, Neel J, Ruslander D, Levy MG, Breitschwerdt EB. Birkenheuer AJ, et al. Among authors: ruslander d. Vet Parasitol. 2004 Oct 5;124(3-4):151-60. doi: 10.1016/j.vetpar.2004.07.008. Vet Parasitol. 2004. PMID: 15381295
Chronic pain: osteoarthritis and cancer.
Kyles AE, Ruslander D. Kyles AE, et al. Among authors: ruslander d. Semin Vet Med Surg Small Anim. 1997 May;12(2):122-32. doi: 10.1016/s1096-2867(97)80009-6. Semin Vet Med Surg Small Anim. 1997. PMID: 9159069 Review.
Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia.
Moore AS, Ruslander D, Cotter SM, Rand WM, L'Heureux DA. Moore AS, et al. Among authors: ruslander d. J Am Vet Med Assoc. 1995 May 15;206(10):1550-4. J Am Vet Med Assoc. 1995. PMID: 7775231
The maximum tolerated dosage was determined to be 2 mg/cat/d given for 3 consecutive days every 3 weeks. Anorexia and leukopenia were found to be dose limiting in cats receiving the drug at a higher dosage. ...Idarubicin (2 mg/cat/d for 3 days, q 3 wks) was used to …
The maximum tolerated dosage was determined to be 2 mg/cat/d given for 3 consecutive days every 3 weeks. Anorexia and leukopenia were …
30 results
Jump to page
Feedback